Last reviewed · How we verify
FLUNIXIN
At a glance
| Generic name | FLUNIXIN |
|---|---|
| Target | Dihydroorotate dehydrogenase (quinone), mitochondrial |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
- Injection site swelling
- Decreased water consumption
- Diarrhea
- Transient inappetence
Serious adverse events
- Anaphylactic-like reactions (fatal)
- Anaphylaxis
- Collapse
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- FLUNIXIN CI brief — competitive landscape report
- FLUNIXIN updates RSS · CI watch RSS